Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04713995 · ClinicalTrials.gov registry record · NA
Microbiome and Axial Spondyloarthritis
A NA study, sponsored by Viome.
- Terminated
- Registry status
- NA
- Development phase
- 95
- Enrollment target
NCT04713995 is a NA study that was terminated before completion, run by Viome. The registered enrollment target is 95 participants.
The verdict
NCT04713995, a NA study, was terminated before completion, sponsored by Viome.
- TERMINATED
- Registry status
- NA
- Development phase
- 95 participants
- Enrollment target
Study Summary
The purpose of this interventional study is to identify the root cause(s) of AxSpA (Axial Spondyloarthritis) relapses, which are likely due to the combination of nutrition, gut microbiome activities, leaky gut, and human genes (particularly from the immune system). This will be done by identifying molecular features of the microbiome that are associated with AxSpA flares, progression and relapses. The study will recruit participants with confirmed AxSpA diagnosis and who are HLA-B27 positive. During screening potential participants allow access to medical records to confirm eligibility requirements, such as diagnosis. Once enrolled, collection kits are sent to participants to collect samples using at-home collection kits and then provide a fasting blood sample at a local lab. Samples are then analyzed to identify features that likely cause AxSpA issues. Survey's are also answered to collect additional health data. Scientists will then use the data to identify the features that likely cause AxSpA flares and relapses.
Interventions
- OTHER Dietary recommendations
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95 participants |
| Start Date | 2020-06-22 |
| Est. Completion | 2022-06-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04713995
The ClinicalTrials.gov registry entry for NCT04713995 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 95 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Viome, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dietary recommendations is the first listed.
NCT04713995 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04713995 about?
NCT04713995 is a clinical study titled "Microbiome and Axial Spondyloarthritis". The purpose of this interventional study is to identify the root cause(s) of AxSpA (Axial Spondyloarthritis) relapses, which are likely due to the combination of nutrition, gut microbiome activities, leaky gut, and human genes (particularly from the immune system). This will be done by identifying m...
What is the current status of trial NCT04713995?
This trial is currently terminated. It is a NA study. The enrollment target is 95 participants. The study started on 2020-06-22. Estimated completion is 2022-06-15.
What interventions are being tested in trial NCT04713995?
The interventions under investigation include: Dietary recommendations (OTHER).
Who is sponsoring clinical trial NCT04713995?
This trial is sponsored by Viome, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.